Global RNA Interference Therapy Supply, Demand and Key Producers, 2024-2030
The global RNA Interference Therapy market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
The RNA Interference Therapy industry is experiencing a dynamic shift towards precision medicine and targeted treatments. Advancements in understanding genetic mechanisms have fueled a surge in RNAi research and development. The trend emphasizes personalized therapies, with a focus on tackling specific gene-related disorders at the molecular level. Improvements in delivery systems, such as nanoparticle technologies, are enhancing the efficiency and specificity of RNA interference. The growing pipeline of RNAi-based drug candidates, especially in oncology and rare diseases, showcases the increasing interest and investment in this therapeutic approach. Overall, the industry trend leans towards unlocking the full potential of RNA Interference Therapy for precise and effective medical interventions.
RNA Interference Therapy, or RNAi Therapy, is a cutting-edge medical approach that utilizes small RNA molecules to selectively silence or regulate targeted genes. This therapeutic method involves introducing synthetic small interfering RNA (siRNA) or microRNA (miRNA) into cells, triggering a natural biological process that inhibits the expression of disease-related genes. RNA Interference Therapy shows promise in treating various conditions, including genetic disorders, viral infections, and certain cancers. By leveraging the specificity of RNA molecules, this therapy holds the potential to revolutionize precision medicine by addressing the root causes of diseases at the genetic level, promoting targeted and personalized treatment strategies.
This report studies the global RNA Interference Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for RNA Interference Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of RNA Interference Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global RNA Interference Therapy total market, 2019-2030, (USD Million)
Global RNA Interference Therapy total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: RNA Interference Therapy total market, key domestic companies and share, (USD Million)
Global RNA Interference Therapy revenue by player and market share 2019-2024, (USD Million)
Global RNA Interference Therapy total market by Type, CAGR, 2019-2030, (USD Million)
Global RNA Interference Therapy total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global RNA Interference Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Silence Therapeutics, Arrowhead Pharmaceuticals, Janssen Research & Development, Sylentis, Sirnaomics, Dicerna Pharmaceuticals, Alnylam Pharmaceuticals, Silenseed and Vir Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World RNA Interference Therapy market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global RNA Interference Therapy Market, By Region:
1. How big is the global RNA Interference Therapy market?
2. What is the demand of the global RNA Interference Therapy market?
3. What is the year over year growth of the global RNA Interference Therapy market?
4. What is the total value of the global RNA Interference Therapy market?
5. Who are the major players in the global RNA Interference Therapy market?
The RNA Interference Therapy industry is experiencing a dynamic shift towards precision medicine and targeted treatments. Advancements in understanding genetic mechanisms have fueled a surge in RNAi research and development. The trend emphasizes personalized therapies, with a focus on tackling specific gene-related disorders at the molecular level. Improvements in delivery systems, such as nanoparticle technologies, are enhancing the efficiency and specificity of RNA interference. The growing pipeline of RNAi-based drug candidates, especially in oncology and rare diseases, showcases the increasing interest and investment in this therapeutic approach. Overall, the industry trend leans towards unlocking the full potential of RNA Interference Therapy for precise and effective medical interventions.
RNA Interference Therapy, or RNAi Therapy, is a cutting-edge medical approach that utilizes small RNA molecules to selectively silence or regulate targeted genes. This therapeutic method involves introducing synthetic small interfering RNA (siRNA) or microRNA (miRNA) into cells, triggering a natural biological process that inhibits the expression of disease-related genes. RNA Interference Therapy shows promise in treating various conditions, including genetic disorders, viral infections, and certain cancers. By leveraging the specificity of RNA molecules, this therapy holds the potential to revolutionize precision medicine by addressing the root causes of diseases at the genetic level, promoting targeted and personalized treatment strategies.
This report studies the global RNA Interference Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for RNA Interference Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of RNA Interference Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global RNA Interference Therapy total market, 2019-2030, (USD Million)
Global RNA Interference Therapy total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: RNA Interference Therapy total market, key domestic companies and share, (USD Million)
Global RNA Interference Therapy revenue by player and market share 2019-2024, (USD Million)
Global RNA Interference Therapy total market by Type, CAGR, 2019-2030, (USD Million)
Global RNA Interference Therapy total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global RNA Interference Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Silence Therapeutics, Arrowhead Pharmaceuticals, Janssen Research & Development, Sylentis, Sirnaomics, Dicerna Pharmaceuticals, Alnylam Pharmaceuticals, Silenseed and Vir Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World RNA Interference Therapy market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global RNA Interference Therapy Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- siRNA
- miRNA
- shRNA
- piRNA
- Cancer Treatment
- Hereditary Disease
- Infectious Disease
- Nervous System Disease
- Diseases of Immune System
- Cardiovascular Disease
- Metabolic Disease
- Silence Therapeutics
- Arrowhead Pharmaceuticals
- Janssen Research & Development
- Sylentis
- Sirnaomics
- Dicerna Pharmaceuticals
- Alnylam Pharmaceuticals
- Silenseed
- Vir Biotechnology
- OliX Pharmaceuticals
- Bio-Path Holdings
- Suzhou Ribo Life Science
1. How big is the global RNA Interference Therapy market?
2. What is the demand of the global RNA Interference Therapy market?
3. What is the year over year growth of the global RNA Interference Therapy market?
4. What is the total value of the global RNA Interference Therapy market?
5. Who are the major players in the global RNA Interference Therapy market?
1 SUPPLY SUMMARY
1.1 RNA Interference Therapy Introduction
1.2 World RNA Interference Therapy Market Size & Forecast (2019 & 2023 & 2030)
1.3 World RNA Interference Therapy Total Market by Region (by Headquarter Location)
1.3.1 World RNA Interference Therapy Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States RNA Interference Therapy Market Size (2019-2030)
1.3.3 China RNA Interference Therapy Market Size (2019-2030)
1.3.4 Europe RNA Interference Therapy Market Size (2019-2030)
1.3.5 Japan RNA Interference Therapy Market Size (2019-2030)
1.3.6 South Korea RNA Interference Therapy Market Size (2019-2030)
1.3.7 ASEAN RNA Interference Therapy Market Size (2019-2030)
1.3.8 India RNA Interference Therapy Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 RNA Interference Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 RNA Interference Therapy Major Market Trends
2 DEMAND SUMMARY
2.1 World RNA Interference Therapy Consumption Value (2019-2030)
2.2 World RNA Interference Therapy Consumption Value by Region
2.2.1 World RNA Interference Therapy Consumption Value by Region (2019-2024)
2.2.2 World RNA Interference Therapy Consumption Value Forecast by Region (2025-2030)
2.3 United States RNA Interference Therapy Consumption Value (2019-2030)
2.4 China RNA Interference Therapy Consumption Value (2019-2030)
2.5 Europe RNA Interference Therapy Consumption Value (2019-2030)
2.6 Japan RNA Interference Therapy Consumption Value (2019-2030)
2.7 South Korea RNA Interference Therapy Consumption Value (2019-2030)
2.8 ASEAN RNA Interference Therapy Consumption Value (2019-2030)
2.9 India RNA Interference Therapy Consumption Value (2019-2030)
3 WORLD RNA INTERFERENCE THERAPY COMPANIES COMPETITIVE ANALYSIS
3.1 World RNA Interference Therapy Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global RNA Interference Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for RNA Interference Therapy in 2023
3.2.3 Global Concentration Ratios (CR8) for RNA Interference Therapy in 2023
3.3 RNA Interference Therapy Company Evaluation Quadrant
3.4 RNA Interference Therapy Market: Overall Company Footprint Analysis
3.4.1 RNA Interference Therapy Market: Region Footprint
3.4.2 RNA Interference Therapy Market: Company Product Type Footprint
3.4.3 RNA Interference Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: RNA Interference Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: RNA Interference Therapy Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: RNA Interference Therapy Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: RNA Interference Therapy Consumption Value Comparison
4.2.1 United States VS China: RNA Interference Therapy Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: RNA Interference Therapy Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based RNA Interference Therapy Companies and Market Share, 2019-2024
4.3.1 United States Based RNA Interference Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies RNA Interference Therapy Revenue, (2019-2024)
4.4 China Based Companies RNA Interference Therapy Revenue and Market Share, 2019-2024
4.4.1 China Based RNA Interference Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies RNA Interference Therapy Revenue, (2019-2024)
4.5 Rest of World Based RNA Interference Therapy Companies and Market Share, 2019-2024
4.5.1 Rest of World Based RNA Interference Therapy Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies RNA Interference Therapy Revenue, (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World RNA Interference Therapy Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 siRNA
5.2.2 miRNA
5.2.3 shRNA
5.2.4 piRNA
5.3 Market Segment by Type
5.3.1 World RNA Interference Therapy Market Size by Type (2019-2024)
5.3.2 World RNA Interference Therapy Market Size by Type (2025-2030)
5.3.3 World RNA Interference Therapy Market Size Market Share by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World RNA Interference Therapy Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Cancer Treatment
6.2.2 Hereditary Disease
6.2.3 Infectious Disease
6.2.4 Nervous System Disease
6.2.5 Nervous System Disease
6.2.6 Cardiovascular Disease
6.2.7 Metabolic Disease
6.3 Market Segment by Application
6.3.1 World RNA Interference Therapy Market Size by Application (2019-2024)
6.3.2 World RNA Interference Therapy Market Size by Application (2025-2030)
6.3.3 World RNA Interference Therapy Market Size by Application (2019-2030)
7 COMPANY PROFILES
7.1 Silence Therapeutics
7.1.1 Silence Therapeutics Details
7.1.2 Silence Therapeutics Major Business
7.1.3 Silence Therapeutics RNA Interference Therapy Product and Services
7.1.4 Silence Therapeutics RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Silence Therapeutics Recent Developments/Updates
7.1.6 Silence Therapeutics Competitive Strengths & Weaknesses
7.2 Arrowhead Pharmaceuticals
7.2.1 Arrowhead Pharmaceuticals Details
7.2.2 Arrowhead Pharmaceuticals Major Business
7.2.3 Arrowhead Pharmaceuticals RNA Interference Therapy Product and Services
7.2.4 Arrowhead Pharmaceuticals RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Arrowhead Pharmaceuticals Recent Developments/Updates
7.2.6 Arrowhead Pharmaceuticals Competitive Strengths & Weaknesses
7.3 Janssen Research & Development
7.3.1 Janssen Research & Development Details
7.3.2 Janssen Research & Development Major Business
7.3.3 Janssen Research & Development RNA Interference Therapy Product and Services
7.3.4 Janssen Research & Development RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Janssen Research & Development Recent Developments/Updates
7.3.6 Janssen Research & Development Competitive Strengths & Weaknesses
7.4 Sylentis
7.4.1 Sylentis Details
7.4.2 Sylentis Major Business
7.4.3 Sylentis RNA Interference Therapy Product and Services
7.4.4 Sylentis RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Sylentis Recent Developments/Updates
7.4.6 Sylentis Competitive Strengths & Weaknesses
7.5 Sirnaomics
7.5.1 Sirnaomics Details
7.5.2 Sirnaomics Major Business
7.5.3 Sirnaomics RNA Interference Therapy Product and Services
7.5.4 Sirnaomics RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Sirnaomics Recent Developments/Updates
7.5.6 Sirnaomics Competitive Strengths & Weaknesses
7.6 Dicerna Pharmaceuticals
7.6.1 Dicerna Pharmaceuticals Details
7.6.2 Dicerna Pharmaceuticals Major Business
7.6.3 Dicerna Pharmaceuticals RNA Interference Therapy Product and Services
7.6.4 Dicerna Pharmaceuticals RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Dicerna Pharmaceuticals Recent Developments/Updates
7.6.6 Dicerna Pharmaceuticals Competitive Strengths & Weaknesses
7.7 Alnylam Pharmaceuticals
7.7.1 Alnylam Pharmaceuticals Details
7.7.2 Alnylam Pharmaceuticals Major Business
7.7.3 Alnylam Pharmaceuticals RNA Interference Therapy Product and Services
7.7.4 Alnylam Pharmaceuticals RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Alnylam Pharmaceuticals Recent Developments/Updates
7.7.6 Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
7.8 Silenseed
7.8.1 Silenseed Details
7.8.2 Silenseed Major Business
7.8.3 Silenseed RNA Interference Therapy Product and Services
7.8.4 Silenseed RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Silenseed Recent Developments/Updates
7.8.6 Silenseed Competitive Strengths & Weaknesses
7.9 Vir Biotechnology
7.9.1 Vir Biotechnology Details
7.9.2 Vir Biotechnology Major Business
7.9.3 Vir Biotechnology RNA Interference Therapy Product and Services
7.9.4 Vir Biotechnology RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Vir Biotechnology Recent Developments/Updates
7.9.6 Vir Biotechnology Competitive Strengths & Weaknesses
7.10 OliX Pharmaceuticals
7.10.1 OliX Pharmaceuticals Details
7.10.2 OliX Pharmaceuticals Major Business
7.10.3 OliX Pharmaceuticals RNA Interference Therapy Product and Services
7.10.4 OliX Pharmaceuticals RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 OliX Pharmaceuticals Recent Developments/Updates
7.10.6 OliX Pharmaceuticals Competitive Strengths & Weaknesses
7.11 Bio-Path Holdings
7.11.1 Bio-Path Holdings Details
7.11.2 Bio-Path Holdings Major Business
7.11.3 Bio-Path Holdings RNA Interference Therapy Product and Services
7.11.4 Bio-Path Holdings RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 Bio-Path Holdings Recent Developments/Updates
7.11.6 Bio-Path Holdings Competitive Strengths & Weaknesses
7.12 Suzhou Ribo Life Science
7.12.1 Suzhou Ribo Life Science Details
7.12.2 Suzhou Ribo Life Science Major Business
7.12.3 Suzhou Ribo Life Science RNA Interference Therapy Product and Services
7.12.4 Suzhou Ribo Life Science RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 Suzhou Ribo Life Science Recent Developments/Updates
7.12.6 Suzhou Ribo Life Science Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 RNA Interference Therapy Industry Chain
8.2 RNA Interference Therapy Upstream Analysis
8.3 RNA Interference Therapy Midstream Analysis
8.4 RNA Interference Therapy Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 RNA Interference Therapy Introduction
1.2 World RNA Interference Therapy Market Size & Forecast (2019 & 2023 & 2030)
1.3 World RNA Interference Therapy Total Market by Region (by Headquarter Location)
1.3.1 World RNA Interference Therapy Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States RNA Interference Therapy Market Size (2019-2030)
1.3.3 China RNA Interference Therapy Market Size (2019-2030)
1.3.4 Europe RNA Interference Therapy Market Size (2019-2030)
1.3.5 Japan RNA Interference Therapy Market Size (2019-2030)
1.3.6 South Korea RNA Interference Therapy Market Size (2019-2030)
1.3.7 ASEAN RNA Interference Therapy Market Size (2019-2030)
1.3.8 India RNA Interference Therapy Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 RNA Interference Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 RNA Interference Therapy Major Market Trends
2 DEMAND SUMMARY
2.1 World RNA Interference Therapy Consumption Value (2019-2030)
2.2 World RNA Interference Therapy Consumption Value by Region
2.2.1 World RNA Interference Therapy Consumption Value by Region (2019-2024)
2.2.2 World RNA Interference Therapy Consumption Value Forecast by Region (2025-2030)
2.3 United States RNA Interference Therapy Consumption Value (2019-2030)
2.4 China RNA Interference Therapy Consumption Value (2019-2030)
2.5 Europe RNA Interference Therapy Consumption Value (2019-2030)
2.6 Japan RNA Interference Therapy Consumption Value (2019-2030)
2.7 South Korea RNA Interference Therapy Consumption Value (2019-2030)
2.8 ASEAN RNA Interference Therapy Consumption Value (2019-2030)
2.9 India RNA Interference Therapy Consumption Value (2019-2030)
3 WORLD RNA INTERFERENCE THERAPY COMPANIES COMPETITIVE ANALYSIS
3.1 World RNA Interference Therapy Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global RNA Interference Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for RNA Interference Therapy in 2023
3.2.3 Global Concentration Ratios (CR8) for RNA Interference Therapy in 2023
3.3 RNA Interference Therapy Company Evaluation Quadrant
3.4 RNA Interference Therapy Market: Overall Company Footprint Analysis
3.4.1 RNA Interference Therapy Market: Region Footprint
3.4.2 RNA Interference Therapy Market: Company Product Type Footprint
3.4.3 RNA Interference Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: RNA Interference Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: RNA Interference Therapy Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: RNA Interference Therapy Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: RNA Interference Therapy Consumption Value Comparison
4.2.1 United States VS China: RNA Interference Therapy Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: RNA Interference Therapy Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based RNA Interference Therapy Companies and Market Share, 2019-2024
4.3.1 United States Based RNA Interference Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies RNA Interference Therapy Revenue, (2019-2024)
4.4 China Based Companies RNA Interference Therapy Revenue and Market Share, 2019-2024
4.4.1 China Based RNA Interference Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies RNA Interference Therapy Revenue, (2019-2024)
4.5 Rest of World Based RNA Interference Therapy Companies and Market Share, 2019-2024
4.5.1 Rest of World Based RNA Interference Therapy Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies RNA Interference Therapy Revenue, (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World RNA Interference Therapy Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 siRNA
5.2.2 miRNA
5.2.3 shRNA
5.2.4 piRNA
5.3 Market Segment by Type
5.3.1 World RNA Interference Therapy Market Size by Type (2019-2024)
5.3.2 World RNA Interference Therapy Market Size by Type (2025-2030)
5.3.3 World RNA Interference Therapy Market Size Market Share by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World RNA Interference Therapy Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Cancer Treatment
6.2.2 Hereditary Disease
6.2.3 Infectious Disease
6.2.4 Nervous System Disease
6.2.5 Nervous System Disease
6.2.6 Cardiovascular Disease
6.2.7 Metabolic Disease
6.3 Market Segment by Application
6.3.1 World RNA Interference Therapy Market Size by Application (2019-2024)
6.3.2 World RNA Interference Therapy Market Size by Application (2025-2030)
6.3.3 World RNA Interference Therapy Market Size by Application (2019-2030)
7 COMPANY PROFILES
7.1 Silence Therapeutics
7.1.1 Silence Therapeutics Details
7.1.2 Silence Therapeutics Major Business
7.1.3 Silence Therapeutics RNA Interference Therapy Product and Services
7.1.4 Silence Therapeutics RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Silence Therapeutics Recent Developments/Updates
7.1.6 Silence Therapeutics Competitive Strengths & Weaknesses
7.2 Arrowhead Pharmaceuticals
7.2.1 Arrowhead Pharmaceuticals Details
7.2.2 Arrowhead Pharmaceuticals Major Business
7.2.3 Arrowhead Pharmaceuticals RNA Interference Therapy Product and Services
7.2.4 Arrowhead Pharmaceuticals RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Arrowhead Pharmaceuticals Recent Developments/Updates
7.2.6 Arrowhead Pharmaceuticals Competitive Strengths & Weaknesses
7.3 Janssen Research & Development
7.3.1 Janssen Research & Development Details
7.3.2 Janssen Research & Development Major Business
7.3.3 Janssen Research & Development RNA Interference Therapy Product and Services
7.3.4 Janssen Research & Development RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Janssen Research & Development Recent Developments/Updates
7.3.6 Janssen Research & Development Competitive Strengths & Weaknesses
7.4 Sylentis
7.4.1 Sylentis Details
7.4.2 Sylentis Major Business
7.4.3 Sylentis RNA Interference Therapy Product and Services
7.4.4 Sylentis RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Sylentis Recent Developments/Updates
7.4.6 Sylentis Competitive Strengths & Weaknesses
7.5 Sirnaomics
7.5.1 Sirnaomics Details
7.5.2 Sirnaomics Major Business
7.5.3 Sirnaomics RNA Interference Therapy Product and Services
7.5.4 Sirnaomics RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Sirnaomics Recent Developments/Updates
7.5.6 Sirnaomics Competitive Strengths & Weaknesses
7.6 Dicerna Pharmaceuticals
7.6.1 Dicerna Pharmaceuticals Details
7.6.2 Dicerna Pharmaceuticals Major Business
7.6.3 Dicerna Pharmaceuticals RNA Interference Therapy Product and Services
7.6.4 Dicerna Pharmaceuticals RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Dicerna Pharmaceuticals Recent Developments/Updates
7.6.6 Dicerna Pharmaceuticals Competitive Strengths & Weaknesses
7.7 Alnylam Pharmaceuticals
7.7.1 Alnylam Pharmaceuticals Details
7.7.2 Alnylam Pharmaceuticals Major Business
7.7.3 Alnylam Pharmaceuticals RNA Interference Therapy Product and Services
7.7.4 Alnylam Pharmaceuticals RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Alnylam Pharmaceuticals Recent Developments/Updates
7.7.6 Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
7.8 Silenseed
7.8.1 Silenseed Details
7.8.2 Silenseed Major Business
7.8.3 Silenseed RNA Interference Therapy Product and Services
7.8.4 Silenseed RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Silenseed Recent Developments/Updates
7.8.6 Silenseed Competitive Strengths & Weaknesses
7.9 Vir Biotechnology
7.9.1 Vir Biotechnology Details
7.9.2 Vir Biotechnology Major Business
7.9.3 Vir Biotechnology RNA Interference Therapy Product and Services
7.9.4 Vir Biotechnology RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Vir Biotechnology Recent Developments/Updates
7.9.6 Vir Biotechnology Competitive Strengths & Weaknesses
7.10 OliX Pharmaceuticals
7.10.1 OliX Pharmaceuticals Details
7.10.2 OliX Pharmaceuticals Major Business
7.10.3 OliX Pharmaceuticals RNA Interference Therapy Product and Services
7.10.4 OliX Pharmaceuticals RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 OliX Pharmaceuticals Recent Developments/Updates
7.10.6 OliX Pharmaceuticals Competitive Strengths & Weaknesses
7.11 Bio-Path Holdings
7.11.1 Bio-Path Holdings Details
7.11.2 Bio-Path Holdings Major Business
7.11.3 Bio-Path Holdings RNA Interference Therapy Product and Services
7.11.4 Bio-Path Holdings RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 Bio-Path Holdings Recent Developments/Updates
7.11.6 Bio-Path Holdings Competitive Strengths & Weaknesses
7.12 Suzhou Ribo Life Science
7.12.1 Suzhou Ribo Life Science Details
7.12.2 Suzhou Ribo Life Science Major Business
7.12.3 Suzhou Ribo Life Science RNA Interference Therapy Product and Services
7.12.4 Suzhou Ribo Life Science RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 Suzhou Ribo Life Science Recent Developments/Updates
7.12.6 Suzhou Ribo Life Science Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 RNA Interference Therapy Industry Chain
8.2 RNA Interference Therapy Upstream Analysis
8.3 RNA Interference Therapy Midstream Analysis
8.4 RNA Interference Therapy Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
.
Table 1. World RNA Interference Therapy Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World RNA Interference Therapy Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World RNA Interference Therapy Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World RNA Interference Therapy Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World RNA Interference Therapy Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World RNA Interference Therapy Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World RNA Interference Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World RNA Interference Therapy Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World RNA Interference Therapy Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key RNA Interference Therapy Players in 2023
Table 12. World RNA Interference Therapy Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global RNA Interference Therapy Company Evaluation Quadrant
Table 14. Head Office of Key RNA Interference Therapy Player
Table 15. RNA Interference Therapy Market: Company Product Type Footprint
Table 16. RNA Interference Therapy Market: Company Product Application Footprint
Table 17. RNA Interference Therapy Mergers & Acquisitions Activity
Table 18. United States VS China RNA Interference Therapy Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China RNA Interference Therapy Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based RNA Interference Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies RNA Interference Therapy Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies RNA Interference Therapy Revenue Market Share (2019-2024)
Table 23. China Based RNA Interference Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies RNA Interference Therapy Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies RNA Interference Therapy Revenue Market Share (2019-2024)
Table 26. Rest of World Based RNA Interference Therapy Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies RNA Interference Therapy Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies RNA Interference Therapy Revenue Market Share (2019-2024)
Table 29. World RNA Interference Therapy Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World RNA Interference Therapy Market Size by Type (2019-2024) & (USD Million)
Table 31. World RNA Interference Therapy Market Size by Type (2025-2030) & (USD Million)
Table 32. World RNA Interference Therapy Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World RNA Interference Therapy Market Size by Application (2019-2024) & (USD Million)
Table 34. World RNA Interference Therapy Market Size by Application (2025-2030) & (USD Million)
Table 35. Silence Therapeutics Basic Information, Area Served and Competitors
Table 36. Silence Therapeutics Major Business
Table 37. Silence Therapeutics RNA Interference Therapy Product and Services
Table 38. Silence Therapeutics RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Silence Therapeutics Recent Developments/Updates
Table 40. Silence Therapeutics Competitive Strengths & Weaknesses
Table 41. Arrowhead Pharmaceuticals Basic Information, Area Served and Competitors
Table 42. Arrowhead Pharmaceuticals Major Business
Table 43. Arrowhead Pharmaceuticals RNA Interference Therapy Product and Services
Table 44. Arrowhead Pharmaceuticals RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Arrowhead Pharmaceuticals Recent Developments/Updates
Table 46. Arrowhead Pharmaceuticals Competitive Strengths & Weaknesses
Table 47. Janssen Research & Development Basic Information, Area Served and Competitors
Table 48. Janssen Research & Development Major Business
Table 49. Janssen Research & Development RNA Interference Therapy Product and Services
Table 50. Janssen Research & Development RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Janssen Research & Development Recent Developments/Updates
Table 52. Janssen Research & Development Competitive Strengths & Weaknesses
Table 53. Sylentis Basic Information, Area Served and Competitors
Table 54. Sylentis Major Business
Table 55. Sylentis RNA Interference Therapy Product and Services
Table 56. Sylentis RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Sylentis Recent Developments/Updates
Table 58. Sylentis Competitive Strengths & Weaknesses
Table 59. Sirnaomics Basic Information, Area Served and Competitors
Table 60. Sirnaomics Major Business
Table 61. Sirnaomics RNA Interference Therapy Product and Services
Table 62. Sirnaomics RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Sirnaomics Recent Developments/Updates
Table 64. Sirnaomics Competitive Strengths & Weaknesses
Table 65. Dicerna Pharmaceuticals Basic Information, Area Served and Competitors
Table 66. Dicerna Pharmaceuticals Major Business
Table 67. Dicerna Pharmaceuticals RNA Interference Therapy Product and Services
Table 68. Dicerna Pharmaceuticals RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Dicerna Pharmaceuticals Recent Developments/Updates
Table 70. Dicerna Pharmaceuticals Competitive Strengths & Weaknesses
Table 71. Alnylam Pharmaceuticals Basic Information, Area Served and Competitors
Table 72. Alnylam Pharmaceuticals Major Business
Table 73. Alnylam Pharmaceuticals RNA Interference Therapy Product and Services
Table 74. Alnylam Pharmaceuticals RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Alnylam Pharmaceuticals Recent Developments/Updates
Table 76. Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
Table 77. Silenseed Basic Information, Area Served and Competitors
Table 78. Silenseed Major Business
Table 79. Silenseed RNA Interference Therapy Product and Services
Table 80. Silenseed RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Silenseed Recent Developments/Updates
Table 82. Silenseed Competitive Strengths & Weaknesses
Table 83. Vir Biotechnology Basic Information, Area Served and Competitors
Table 84. Vir Biotechnology Major Business
Table 85. Vir Biotechnology RNA Interference Therapy Product and Services
Table 86. Vir Biotechnology RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Vir Biotechnology Recent Developments/Updates
Table 88. Vir Biotechnology Competitive Strengths & Weaknesses
Table 89. OliX Pharmaceuticals Basic Information, Area Served and Competitors
Table 90. OliX Pharmaceuticals Major Business
Table 91. OliX Pharmaceuticals RNA Interference Therapy Product and Services
Table 92. OliX Pharmaceuticals RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. OliX Pharmaceuticals Recent Developments/Updates
Table 94. OliX Pharmaceuticals Competitive Strengths & Weaknesses
Table 95. Bio-Path Holdings Basic Information, Area Served and Competitors
Table 96. Bio-Path Holdings Major Business
Table 97. Bio-Path Holdings RNA Interference Therapy Product and Services
Table 98. Bio-Path Holdings RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. Bio-Path Holdings Recent Developments/Updates
Table 100. Suzhou Ribo Life Science Basic Information, Area Served and Competitors
Table 101. Suzhou Ribo Life Science Major Business
Table 102. Suzhou Ribo Life Science RNA Interference Therapy Product and Services
Table 103. Suzhou Ribo Life Science RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 104. Global Key Players of RNA Interference Therapy Upstream (Raw Materials)
Table 105. RNA Interference Therapy Typical Customers
LIST OF FIGURE
.
Figure 1. RNA Interference Therapy Picture
Figure 2. World RNA Interference Therapy Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World RNA Interference Therapy Total Market Size (2019-2030) & (USD Million)
Figure 4. World RNA Interference Therapy Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World RNA Interference Therapy Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company RNA Interference Therapy Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company RNA Interference Therapy Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company RNA Interference Therapy Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company RNA Interference Therapy Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company RNA Interference Therapy Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company RNA Interference Therapy Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company RNA Interference Therapy Revenue (2019-2030) & (USD Million)
Figure 13. RNA Interference Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 16. World RNA Interference Therapy Consumption Value Market Share by Region (2019-2030)
Figure 17. United States RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 18. China RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 23. India RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of RNA Interference Therapy by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for RNA Interference Therapy Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for RNA Interference Therapy Markets in 2023
Figure 27. United States VS China: RNA Interference Therapy Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: RNA Interference Therapy Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World RNA Interference Therapy Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World RNA Interference Therapy Market Size Market Share by Type in 2023
Figure 31. siRNA
Figure 32. miRNA
Figure 33. shRNA
Figure 34. piRNA
Figure 35. World RNA Interference Therapy Market Size Market Share by Type (2019-2030)
Figure 36. World RNA Interference Therapy Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 37. World RNA Interference Therapy Market Size Market Share by Application in 2023
Figure 38. Cancer Treatment
Figure 39. Hereditary Disease
Figure 40. Infectious Disease
Figure 41. Nervous System Disease
Figure 42. Diseases of Immune System
Figure 43. Cardiovascular Disease
Figure 44. Metabolic Disease
Figure 45. RNA Interference Therapy Industrial Chain
Figure 46. Methodology
Figure 47. Research Process and Data Source
.
Table 1. World RNA Interference Therapy Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World RNA Interference Therapy Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World RNA Interference Therapy Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World RNA Interference Therapy Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World RNA Interference Therapy Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World RNA Interference Therapy Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World RNA Interference Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World RNA Interference Therapy Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World RNA Interference Therapy Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key RNA Interference Therapy Players in 2023
Table 12. World RNA Interference Therapy Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global RNA Interference Therapy Company Evaluation Quadrant
Table 14. Head Office of Key RNA Interference Therapy Player
Table 15. RNA Interference Therapy Market: Company Product Type Footprint
Table 16. RNA Interference Therapy Market: Company Product Application Footprint
Table 17. RNA Interference Therapy Mergers & Acquisitions Activity
Table 18. United States VS China RNA Interference Therapy Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China RNA Interference Therapy Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based RNA Interference Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies RNA Interference Therapy Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies RNA Interference Therapy Revenue Market Share (2019-2024)
Table 23. China Based RNA Interference Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies RNA Interference Therapy Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies RNA Interference Therapy Revenue Market Share (2019-2024)
Table 26. Rest of World Based RNA Interference Therapy Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies RNA Interference Therapy Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies RNA Interference Therapy Revenue Market Share (2019-2024)
Table 29. World RNA Interference Therapy Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World RNA Interference Therapy Market Size by Type (2019-2024) & (USD Million)
Table 31. World RNA Interference Therapy Market Size by Type (2025-2030) & (USD Million)
Table 32. World RNA Interference Therapy Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World RNA Interference Therapy Market Size by Application (2019-2024) & (USD Million)
Table 34. World RNA Interference Therapy Market Size by Application (2025-2030) & (USD Million)
Table 35. Silence Therapeutics Basic Information, Area Served and Competitors
Table 36. Silence Therapeutics Major Business
Table 37. Silence Therapeutics RNA Interference Therapy Product and Services
Table 38. Silence Therapeutics RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Silence Therapeutics Recent Developments/Updates
Table 40. Silence Therapeutics Competitive Strengths & Weaknesses
Table 41. Arrowhead Pharmaceuticals Basic Information, Area Served and Competitors
Table 42. Arrowhead Pharmaceuticals Major Business
Table 43. Arrowhead Pharmaceuticals RNA Interference Therapy Product and Services
Table 44. Arrowhead Pharmaceuticals RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Arrowhead Pharmaceuticals Recent Developments/Updates
Table 46. Arrowhead Pharmaceuticals Competitive Strengths & Weaknesses
Table 47. Janssen Research & Development Basic Information, Area Served and Competitors
Table 48. Janssen Research & Development Major Business
Table 49. Janssen Research & Development RNA Interference Therapy Product and Services
Table 50. Janssen Research & Development RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Janssen Research & Development Recent Developments/Updates
Table 52. Janssen Research & Development Competitive Strengths & Weaknesses
Table 53. Sylentis Basic Information, Area Served and Competitors
Table 54. Sylentis Major Business
Table 55. Sylentis RNA Interference Therapy Product and Services
Table 56. Sylentis RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Sylentis Recent Developments/Updates
Table 58. Sylentis Competitive Strengths & Weaknesses
Table 59. Sirnaomics Basic Information, Area Served and Competitors
Table 60. Sirnaomics Major Business
Table 61. Sirnaomics RNA Interference Therapy Product and Services
Table 62. Sirnaomics RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Sirnaomics Recent Developments/Updates
Table 64. Sirnaomics Competitive Strengths & Weaknesses
Table 65. Dicerna Pharmaceuticals Basic Information, Area Served and Competitors
Table 66. Dicerna Pharmaceuticals Major Business
Table 67. Dicerna Pharmaceuticals RNA Interference Therapy Product and Services
Table 68. Dicerna Pharmaceuticals RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Dicerna Pharmaceuticals Recent Developments/Updates
Table 70. Dicerna Pharmaceuticals Competitive Strengths & Weaknesses
Table 71. Alnylam Pharmaceuticals Basic Information, Area Served and Competitors
Table 72. Alnylam Pharmaceuticals Major Business
Table 73. Alnylam Pharmaceuticals RNA Interference Therapy Product and Services
Table 74. Alnylam Pharmaceuticals RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Alnylam Pharmaceuticals Recent Developments/Updates
Table 76. Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
Table 77. Silenseed Basic Information, Area Served and Competitors
Table 78. Silenseed Major Business
Table 79. Silenseed RNA Interference Therapy Product and Services
Table 80. Silenseed RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Silenseed Recent Developments/Updates
Table 82. Silenseed Competitive Strengths & Weaknesses
Table 83. Vir Biotechnology Basic Information, Area Served and Competitors
Table 84. Vir Biotechnology Major Business
Table 85. Vir Biotechnology RNA Interference Therapy Product and Services
Table 86. Vir Biotechnology RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Vir Biotechnology Recent Developments/Updates
Table 88. Vir Biotechnology Competitive Strengths & Weaknesses
Table 89. OliX Pharmaceuticals Basic Information, Area Served and Competitors
Table 90. OliX Pharmaceuticals Major Business
Table 91. OliX Pharmaceuticals RNA Interference Therapy Product and Services
Table 92. OliX Pharmaceuticals RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. OliX Pharmaceuticals Recent Developments/Updates
Table 94. OliX Pharmaceuticals Competitive Strengths & Weaknesses
Table 95. Bio-Path Holdings Basic Information, Area Served and Competitors
Table 96. Bio-Path Holdings Major Business
Table 97. Bio-Path Holdings RNA Interference Therapy Product and Services
Table 98. Bio-Path Holdings RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. Bio-Path Holdings Recent Developments/Updates
Table 100. Suzhou Ribo Life Science Basic Information, Area Served and Competitors
Table 101. Suzhou Ribo Life Science Major Business
Table 102. Suzhou Ribo Life Science RNA Interference Therapy Product and Services
Table 103. Suzhou Ribo Life Science RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 104. Global Key Players of RNA Interference Therapy Upstream (Raw Materials)
Table 105. RNA Interference Therapy Typical Customers
LIST OF FIGURE
.
Figure 1. RNA Interference Therapy Picture
Figure 2. World RNA Interference Therapy Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World RNA Interference Therapy Total Market Size (2019-2030) & (USD Million)
Figure 4. World RNA Interference Therapy Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World RNA Interference Therapy Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company RNA Interference Therapy Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company RNA Interference Therapy Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company RNA Interference Therapy Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company RNA Interference Therapy Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company RNA Interference Therapy Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company RNA Interference Therapy Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company RNA Interference Therapy Revenue (2019-2030) & (USD Million)
Figure 13. RNA Interference Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 16. World RNA Interference Therapy Consumption Value Market Share by Region (2019-2030)
Figure 17. United States RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 18. China RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 23. India RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of RNA Interference Therapy by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for RNA Interference Therapy Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for RNA Interference Therapy Markets in 2023
Figure 27. United States VS China: RNA Interference Therapy Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: RNA Interference Therapy Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World RNA Interference Therapy Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World RNA Interference Therapy Market Size Market Share by Type in 2023
Figure 31. siRNA
Figure 32. miRNA
Figure 33. shRNA
Figure 34. piRNA
Figure 35. World RNA Interference Therapy Market Size Market Share by Type (2019-2030)
Figure 36. World RNA Interference Therapy Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 37. World RNA Interference Therapy Market Size Market Share by Application in 2023
Figure 38. Cancer Treatment
Figure 39. Hereditary Disease
Figure 40. Infectious Disease
Figure 41. Nervous System Disease
Figure 42. Diseases of Immune System
Figure 43. Cardiovascular Disease
Figure 44. Metabolic Disease
Figure 45. RNA Interference Therapy Industrial Chain
Figure 46. Methodology
Figure 47. Research Process and Data Source
